Goldman Sachs’s Dermira, Inc. DERM Stock Holding History

Goldman Sachs’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-15,000	Closed	-$417K	–	6569
2017 Q4	$417K	Hold	15,000	–	–	﹤0.01%	4973
2017 Q3	$405K	Sell	15,000 -7,500	-33%	-$196K	﹤0.01%	5255
2017 Q2	$656K	Sell	22,500 -20,000	-47%	-$608K	﹤0.01%	4850
2017 Q1	$1.45M	Buy	+42,500	New	+$1.37M	﹤0.01%	4047
2016 Q4	–	Sell	-115,000	Closed	-$3.89M	–	7193
2016 Q3	$3.89M	Buy	115,000 +110,000	+2,200%	+$3.54M	﹤0.01%	3262
2016 Q2	$146K	Buy	+5,000	New	+$138K	﹤0.01%	5912

Goldman Sachs's DERM Position: Q1 2020 in Review

Goldman Sachs sold out of Dermira, Inc. (DERM) in Q1 2020, closing a stake of 199,477 shares — an estimated $3.02M sold.

Goldman Sachs first reported a position in DERM in Q4 2014 and held it in 21 quarters. The position peaked at $9.86M in Q3 2016. 0 funds tracked by Wall St. Rank hold DERM as of Q1 2020.

Goldman Sachs reported no remaining Dermira, Inc. position as of Q1 2020 after selling out during the quarter.
Goldman Sachs sold 199,477 Dermira, Inc. shares in Q1 2020, an estimated $3.02M.
Goldman Sachs first reported a position in Dermira, Inc. in Q4 2014 and held it in 21 quarters.
Goldman Sachs's Dermira, Inc. position peaked at $9.86M in Q3 2016.
0 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2020.

Based on Goldman Sachs's 13F filing for Q1 2020, filed 15 May 2020.